PRP-FDïŒPFC-FDïŒæ³šå°ãšã¯

PRPãšã¯ãPlatelet-Rich PlasmaïŒå€è¡å°æ¿è¡æŒ¿ïŒãã®ç¥ç§°ã§ãè¡æ¶²äžã®è¡å°æ¿ãæ¿çž®ãããã®ã§ãããã§ã«èšåºã§ãåºã䜿ãããŠãããçŸåšã§ã¯å€åœ¢æ§é¢ç¯çã®æ²»çã¯ãã¡ãããæ¯ãã¢ã¹ãªãŒãã®ã±ã¬ã®æ²»çãããã«ã¯çŸå®¹æœè¡ã«ãŸã§çšããããŠããŸãããããå
šãŠã«å
±éããã®ã¯ãè¡å°æ¿ãæŸåºããæé·å åã®åããå¿çšããæ²»çã ãšããããšã§ãã
åœé¢ããæäŸããPRP-FDïŒPFC-FDïŒæ³šå°ã§ã¯ãPRPã«å«ãŸããæé·å åãããã«æ¿çž®ã»æŽ»æ§åããããã®ãããªãŒãºãã©ã€ïŒFDïŒå å·¥ãããããæ³šå°å€ãšããŠæäžããŸãã
å€åœ¢æ§èé¢ç¯æ²»çã§æåŸ
ã§ããæ²»ç广ã¯ãèé¢ç¯å
ã®ççãæããããšã§ããããããçã¿ã®æ¹åãšãé¢ç¯å¯ååã®æ¡å€§ã§ããå®éãåœé¢ã§ã¯ããã¢ã«ãã³é
žæ³šå°ã§æ¹åãåŸãããªãå€åœ¢æ§ã²ãé¢ç¯çã®æ£è
æ§ãžã®æçšæ§ã確èªãããŠããŸã[1][2]ã
ãã®ãããªæ¹ã ã«ããããã§ã
PRP-FDïŒPFC-FDïŒæ³šå°ã¯æ¬¡ã®ãããªãæ©ã¿ã®ããæ¹ã«ããããã§ãã
è¬ç©æ²»çããã¢ã«ãã³é žæ³šå°ãè¡ãªã£ãŠããã®ã«çã¿ãæ¹åããªã

é·æéåãæ²»çãç¶ããŠããã®ã«å¹æã宿ã§ããªãããŸãã¯ä»¥åã¯å¹æãæãããããæè¿ã¯æããããªããªã£ããšããæ¹ã¯ãèé¢ç¯ã®æå·ãé²è¡ããŠããå¯èœæ§ããããŸãã
PRP-FDïŒPFC-FDïŒã¯çã¿ã®åå ã§ããççãæå¶ã
çã¿ã®è»œæžãæåŸ
ã§ããŸãã
æè¡ãå§ããããŠããããé·æéã®å ¥é¢ããªãããªã¯é£ãã

人工é¢ç¯ã®çœ®æè¡ãªã©ãèé¢ç¯ã®æè¡ã«ã¯é·æéã®å
¥é¢ããªãããªãèŠãããã®ãå°ãªããããŸãããä»äºãå®¶åºã®äºæ
çã§ãããã察å¿ãé£ããæ¹ãããã£ãããããšãšæããŸãã
PRP-FDïŒPFC-FDïŒã®æ²»çã¯æ¡è¡ãšæ³šå°ã®ã¿ã
å
¥é¢ã®å¿
èŠã¯ãããŸããã
äœåºŠãé »ç¹ã«éé¢ããã®ã¯ç ©ããã

çã¿æ¢ãããã¢ã«ãã³é
žæ³šå°ãªã©ã®å Žåãå¹æã®æç¶æ§ã¯äžæçã§ããããšãã»ãšãã©ã§ããèé¢ç¯çã®æ²»çããé·æéã«åã¶ããšãå°ãªããããŸããã
PRP-FDïŒPFC-FDïŒã¯æç¶çãªå¹æãæåŸ
ã§ããŸãã
察ççæ³çãªæ²»çã®ãããªé »ç¹ãªéé¢ã¯äžèŠã§ãã
PRP-FDïŒPFC-FDïŒã®ã¡ãªããïŒãã¡ãªãã
äºåã«ç¥ã£ãŠãããŠããã ããããPRP-FDïŒPFC-FDïŒã®ã¡ãªãããšãã¡ãªããã«ã€ããŠã玹ä»ããŸãã
| ã¡ãªãã | ãã¡ãªãã |
| æ³šå°æ²»çãªã®ã§ãæè¡ã«æ¯ã¹ãŠäœäŸµè¥²ïŒå ¥é¢ãªãïŒ | æ²»çã®å¹æãæç¶æéã«å人差ããã |
| å¯äœçšã®ãªã¹ã¯ãå°ãªããã¹ããã€ã泚å°ã«æ¯ã¹ç¹°ãè¿ãæäžå¯èœ | ä¿éºé©çšå€ã®æ²»çãªã®ã§ãèªç±èšºçã§ã®æäŸã«éããã |
| ãã¢ã«ãã³é žæ³šå°ãªã©ã«æ¯ã¹ãé·æéã®å¹æãæåŸ ã§ãã | æå¹ç©è³ªãåå¿ããŠå¹æãã§ããŸã§ãïŒãµæã»ã©ããã |
ã¡ãªãã
åŸæ¥ã®æ²»çæ³ã§è§£æ±ºã§ããªãã£ãçã¿ã®æ¹åãæåŸ
ã§ããããšããäœãžã®è² æ
ã軜ãããšãªã©ãæããããŸãã
â æ³šå°ã ãã®æ²»çãªã®ã§äœã«å·ãæ®ããŸããã
â¶ïžäœãžã®è² æ
ã軜ããé«éœ¢ã®æ¹ã§ãç¡çãªãåããŠããã ããŸããâ å¹æã®æç¶æ§ãæåŸ
ã§ããŸãã
â¶ïž1åºŠã®æ²»çã§ãæ°ãµæãã1幎çšåºŠæ¹å广ãæç¶ããŸããâ å¯äœçšã®å¿é
ã¯ã»ãšãã©ãããŸããã
â¶ïžèªå·±è¡æ¶²ãå©çšããã®ã§ãã¢ã¬ã«ã®ãŒåå¿ãæåŠåå¿ã®å¿é
ã¯ã»ãšãã©ãããŸããã
ãã¡ãªãã
é©å¿æ£è
ã®èŠæ¥µããªã©ã«é¢ãããšããã³ã¹ã®ç¢ºç«ãåŸ
ãããŸãããã®ã»ããçµæžçãªè² æ
ãå°ãªããããŸããã
â 广ã«ã¯å人差ãããã
â¶ïžMRIæ€æ»ã§ããçšåºŠäºæž¬ã§ããŸãããå
šãŠã®äººã«åçã®å¹æã¯ãçŽæã§ããŸãããâ å³å¹æ§ã¯æåŸ
ã§ããªãã
â¶ïžæå¹ç©è³ªãåå¿ããŠå¹æãšããŠçŸãããŸã§ã«ãçŽ1ãµæçšåºŠèŠããŸããâ ä¿éºãé©å¿ãããŸããã
â¶ïžæ°ããæ²»çæ³ãªã®ã§å
¬çä¿éºãæ°éä¿éºãšãé©å¿å€ã§ãã
ãåèãªã³ã¯ã
Q: PRPçæ³ã®å¯äœçšã«ã€ããŠæããŠãã ããã
Q: PRP-FDïŒPFC-FDïŒæ³šå°ã¯è€æ°ååããå Žåãå¹æã¯æåŸ
ã§ããŸããïŒ
åœé¢ãPRP-FDïŒPFC-FDïŒæ³šå°ããæäŸããçç±

PRPãæ¿çž®ããPRP-FDïŒPFC-FDïŒã«ã¯ã掻æ§åããæé·å åãPRPã®çŽ2åå«ãŸããŠããŸã[4]ã
ãã®éãããããåœé¢ã®å€åœ¢æ§èé¢ç¯çã®æ²»çããŒã¿ã«ãããŠã¯ãPRP-FDïŒPFC-FDïŒæ³šå°ã®æ¹ãPRPããçã¿ã®æ¹åã倧ãããç¶ç¶çãªå¹æãåŸãããŠããŸãã[5]ã
ãã®ãããåœé¢ã§ã¯PRP-FDïŒPFC-FDïŒæ³šå°ããæäŸããŠããŸãã
PRP-FDïŒPFC-FDïŒæ³šå°ã®äœçšã®è£åŽ
ç§ãã¡ããã®æ²»çæ³ããææ¡ããçç±ã¯ãè¡å°æ¿ç±æ¥ã®æé·å åã«ç¹çãã¹ã3ã€ã®äœçšããããšèããŠããããã§ãã
ïŒ.ã³ã©ãŒã²ã³ã®ç£ç
ã³ã©ãŒã²ã³ã¯éªšãè¡ç®¡ãã€ããããã«ã«æ¬ ãããªãæåãªã®ã§ããããã®ã³ã©ãŒã²ã³ãæ°ããçã¿åºãããŸãã
ïŒ.修埩现èã®æé
çµç¹ã®ä¿®åŸ©ã«å¯Ÿå¿ãã现èããèé¢ç¯ã«åŒã³å¯ããã·ã°ãã«ãçºä¿¡ããŸãã
ïŒ.现èåè£ã®æŽ»æ§å
èªå·±ä¿®åŸ©æ©èœãäžæ¬¡çã«é«ãŸãããã¡ãŒãžã®æ²»çãæåŸ ã§ããŸãã

PRP-FDïŒPFC-FDïŒã«å«ãŸããè¡æ¶²ç±æ¥ã®æé·å åã®ããããåãã«ã¯ãä»ãæ©ã¿ã®ççã«ãã匷ãçã¿ãæ¹åããã²ãé¢ç¯ãåããããããã广ãæåŸ ã§ããŸãã
å¹é€å¹¹çŽ°èæ²»çãšã®éã
èªå·±è¡æ¶²ã掻çšããPRP-FDïŒPFC-FDïŒæ³šå°ã¯ãä»ã®ççãçã¿ãæ¹åããããšãåžæã®æ¹ã«ããããã§ãã
åœé¢ã§ã¯ãMRIæ€æ»ã§ã²ãé¢ç¯ã®è©³çްãªç¶æ
ãææ¡ãã蚺å¯ã§åããªã©ã確èªããäžã§ãå°éå»ãç·å蚺æããŠé©ããæ²»çããææ¡ããŸãã


泚æç¹
PRPçæ³ã¯ããã¢ã«ãã³é
žãççé£å¡©æ°Žã®æäžãšã®æ¯èŒã«ãããŠãæå®³äºè±¡ã®ãªã¹ã¯ãäžæãããªãããšãå ±åãããŠããŸã[3]ãPRP-FDïŒPFC-FDïŒæ³šå°ã§ã¯ãé¢ç¯å
ã®ææãè¡æ ãæè¡çãã¢ã¬ã«ã®ãŒåå¿ãé¢ç¯å
åºè¡ãšãã£ããªã¹ã¯ãèããããŸãããåœã°ã«ãŒãã®31,200äŸã«ç»ãéå»ã®çäŸãæ¯ãè¿ã£ãŠãããã®ãããªäºè±¡ã¯èŠãããŸããã§ããã
ãã ããæ³šå°ã«äŒŽãææãç¥çµã»è¡ç®¡æå·ã®ãªã¹ã¯ã¯èããããŸãã®ã§ãäžå®ãªçç¶ãªã©ãããŸãããéããã«ãç³ãä»ããã ããã
ãªãæ£è
æ§ã«ã¯ãæ²»ç广ãæå€§éã«ãããããæ¬¡ã®ïŒç¹ã泚æç¹ãšããŠãäŒãããŠããŸãã
ãæ²»çåŸã®æ³šæç¹ã
ïŒ.PRP-FDïŒPFC-FDïŒæ³šå°ãè¡ã£ãåœæ¥ã¯ãå ¥æµŽã¯æ§ãã·ã£ã¯ãŒã®ã¿ã«ããŠãã ãããç¿æ¥ããå ¥æµŽå¯èœã§ãããæ²»çåŸïŒãïŒæ¥ã¯é·æ¹¯ã¯é¿ããŠãã ãããïŒ.æ£éšãè «ããããšãããã®ã§ãæ²»çåŸïŒãïŒæ¥ã¯éåã¯é¿ããŠãã ããïŒæ²»çéšäœã«è «ãçããªããã°åéå¯èœã§ãïŒãïŒ.æ²»çåŸïŒãïŒãµæã»ã©ã¯ããªãã¹ãèã«é床ãªè² æ ããããªãããã«ããŠãã ãããå ·äœçã«ã¯é·æéã®æ©è¡ããéæ®µæéã¯çŠç©ã§ãããã ããè² è·ã®å°ãªã倪ããã®çãã¬ãã²ãã®æ²ã䌞ã°ãéåãªã©ã¯ç©æ¥µçã«è¡ã£ãŠãã ããã
æ²»çã®æµã
-

ïŒ.å蚺ã®ãäºçŽ
åœé¢ã¯å®å šäºçŽå¶ã§ãã
åŸ ã¡æéãæ··éã®å¿é ã¯ãããŸããã -

ïŒ.æ€æ»ïŒèšºå¯
ãäºçŽããã ããæ¥æã«ãæ¥é¢ããã ããMRIæ€æ»ãšå»åž«ã«ãã蚺å¯ãåããŠããã ããŸãã
ãã§ã«MRIç»åããæã¡ã®æ¹ã¯ãæ€æ»ãçç¥ããããšãå¯èœã§ãã -

ïŒ.æ¡è¡
æ€æ»ãšèšºå¯ã®çµæãPRP-FDïŒPFC-FDïŒæ³šå°ã®é©å¿ããããšèšºæããããã€æ²»çå 容ã«ã€ããŠãçŽåŸããã ããå Žåã¯ããã®æ¥ã®ãã¡ã«æ¡è¡ãããŠããã ãããšãã§ããŸãã
æ²»çãåãããã©ããè¿·ãããå Žåã¯ãäžæŠæã¡åž°ã£ãŠãæ€èšããã ãããšãå¯èœã§ãã -

ïŒ.è¡æ¶²æ€æ»ïŒå å·¥
åçåŽåçããèš±å¯ãåŸãŠããè¡æ¶²å å·¥ã»ã³ã¿ãŒã§ãæ¡åããè¡æ¶²ããã§ãã¯ããåé¡ããªããã°PRP-FDïŒPFC-FDïŒãçæããŠãããŸããè¡æ¶²ã®å å·¥ã«ã¯çŽ3é±éã»ã©ãæéãããã ããŸãã
-

ïŒ.æ²»ç
PRP-FDïŒPFC-FDïŒã®å å·¥ãå®äºããããååºŠãæ¥é¢ããã ããŸãã
å å·¥ããPRP-FDïŒPFC-FDïŒãèé¢ç¯ãè ±ã«æ³šå ¥ããŠãããŸãã
è²»çš
PRP-FDïŒPFC-FDïŒæ³šå°ã®è²»çšã«ã€ããŠã¯ãæéããŒãžã«ãŠãæ¡å ããŠãããŸãããŸããåœé¢ã®æ²»çã¯èªç±èšºçã«ãªããŸãããå»çè²»æ§é€å¶åºŠãé©å¿ãããå ŽåããããŸãã䜵ããŠå 容ãã確èªãã ããã
ãããã質å
PRPãšPRP-FDïŒPFC-FDïŒã®éãã¯äœã§ããïŒ

PRP-FDïŒPFC-FDïŒã«å«ãŸããæé·å åã¯PRPã®çŽ2åã§ã[4]ããŸããããªãŒãºãã©ã€å å·¥ãããã®ã§ãPRPã«æ¯ã¹ãŠé·æéã®ä¿åãå¯èœã«ãªããŸãããå ããŠãPRP-FDïŒPFC-FDïŒã«ã¯æé·å å以å€ã®äœåãªæåãã»ãšãã©å«ãŸããªãããšãããæ³šå°åŸã®åå¿çãå°ãªãã§ããããããç¹ã¯ãPRP-FDïŒPFC-FDïŒã®å©ç¹ãšèããããŸãã
äžæ¹ã§ãPRPãæ¡è¡ãããã®æ¥ã«æ²»çãçµããããã®ã«å¯ŸããŠãPRP-FDïŒPFC-FDïŒã¯è¡æ¶²ã®å å·¥ã«3é±éã»ã©æéãèŠããŸããæ²»çå®äºãŸã§ã«æéãèŠããŸãã®ã§ããã®ç¹ã¯ãã¡ãªããã§ãã
广ã«ã€ããŠã¯ãå¥åããã±ãŒã¹ãšããã§ãªãã±ãŒã¹ãããããã§ãçµè«ã«ã¯è³ã£ãŠããŸãããåœé¢ã§ã¯åå¥ã«ç¶æ
ãèŠãŸããŠããã ããªãããæåã®æ¹æ³ããææ¡ããŠããŸãã
| PRPçæ³ | PRP-FDïŒPFC-FDïŒæ³šå° | |
| æ²»çãŸã§ èŠããæé |
åœæ¥å®äº | çŽïŒã¶æ ïŒè¡æ¶²å å·¥ã«ïŒé±éïŒ |
| 泚å
¥ãã æé·å åã®é |
å°ãªã ïŒPRP-FDïŒPFC-FDïŒã®ååçšåºŠïŒ |
å€ã ïŒPRPçæ³ã®çŽïŒåïŒ |
| é·æä¿å | äžå¯ | å¯èœ ïŒæå€§ïŒã¶æïŒ |
| æ²»ç广 | å¥åããã±ãŒã¹ãšããã§ãªãã±ãŒã¹ããã ïŒå°éã®å»åž«ã«èŠç¢ºèªïŒ |
|
æ²»çåŸã®çæŽ»ã§æ³šæãã¹ãç¹ãæããŠãã ããã
æ£éšãè
«ããããšãããã®ã§ãæ²»çãã2ã3æ¥ã®éã¯æ¿ããéåã¯æ§ããããã«ããŠãã ããããŸããæ²»çåŸ3ãµæãããã®éã¯ããŠã©ãŒãã³ã°ãéæ®µã®äžãäžããªã©ãèã«è² æ
ã®ãããéåã¯æ§ããŠãã ããã
æ²»çã«ãè¶ãããã ããéã«ãªãããªæ¹æ³ããäŒãããŸãã®ã§ããèªå®
ã§ããŸãã«å±ãã§ãã ããã°ãšæããŸãã
1åã®æ³šå ¥ã§ãå¹æã¯æåŸ ã§ããŸããïŒ
èã®ãç¶æ ã«ããããŸããã1åã®æ³šå ¥ã§ã广ãã宿ããã ããã±ãŒã¹ã¯ãããŸãããã ããé¢ç¯ã®æå·ãæ¿ããå Žåã¯é£ãããããããŸããããã®èŸºãã¯MRIã®ç»åãèŠãããŠããã ããšããªãã¯ã£ãããããšæããŸãã®ã§ã蚺å¯ã®éã«ã¯æç¢ºã«ãçãã§ããŸãã
å€åœ¢æ§èé¢ç¯ç以å€ã¯é©å¿ã«ãªããŸãããïŒ
ããããé¢ç¯åšå²ã®ççæ§ç
å€ïŒé垯ãè
±ã®ççïŒãé垯ãåææ¿ã®æå·ãšãã£ãã¹ããŒãå€å·ãé©å¿ã«ãªããŸãã
å€åœ¢æ§èé¢ç¯çã«é¢ããŠã¯åæããæ«æãŸã§ç
æãåãã察å¿å¯èœã§ãããåçå»çã®å¹æãèŠèŸŒããªããšå€æããå Žåã¯ãé©å¿å€ãšãªãããšããããŸãããããã«ããã蚺å¯ã®äžæ±ºå®ãããŠããã ããŸãã
é©å¿ã«ãªããªãã®ã¯ã©ããªå Žåã§ããïŒ
æªæ§è
«çãé床ã®ç³å°¿ç
ãææçããæã¡ã®æ¹ã¯é©å¿ãšãªããŸããã
æªæ§è
«çããæã¡ã®æ¹ã«ã€ããŠã¯ãPRP-FDïŒPFC-FDïŒã«ãã£ãŠè
«çã®å¢æ®ãåŸæŒããããå¯èœæ§ãåŠå®ã§ããªããããé©å¿å€ãšãããŠããã ãå ŽããããŸãïŒPRP-FDïŒPFC-FDïŒã«ã¯è€æ°ã®æé·å åãå«ãŸããŠããããããã®äžã«ã¯è
«çã®å¢æ®ãåŸæŒãããåããæã£ããã®ãå«ãŸããå¯èœæ§ããããŸãïŒã
ãŸããç³å°¿ç
ã®æ¹ã«ã€ããŠã¯ãè¡æ¶²ã®åºãŸããããïŒååºèœïŒãå¢å¹
ãããå±éºãããããšãããé床ã®ç³å°¿ç
ã®æ¹ãžã®æäžã¯ãæãããããšããããŸããè¡æ¶²ãåºãŸãããããšãå¿çæ¢å¡ãè³æ¢å¡ãªã©ãåœã«é¢ããçŸæ£ãåŒãèµ·ããå±éºãé«ããªãããã§ãã
ææçã«ã€ããŠãåæ§ã§ãè¡æ¶²ãåºãŸãããããªã£ãŠããããšããããã®å±éºæ§ãèæ
®ããŠæäžãèŠåãããããšããããŸãã
èæ³š
- [1]â§çœç°æºåœŠã»ã å€åœ¢æ§èé¢ç¯çã«å¯Ÿãåçå»çãšããŠæœè¡ããèªå·±è¡ç±æ¥PRPãçšããPFC-FD(platelet-derived factor concentrate freeze dry)æ²»çã®èšåºæçžŸç¬¬32åæ¥æ¬æŽåœ¢å€ç§åŠäŒåºç€åŠè¡éäŒïŒããã«ãã£ã¹ã«ãã·ã§ã³ïŒ 2017
- [2]â§æšªç°çŽæ£ã»ã å€åœ¢æ§èé¢ç¯çã«å¯Ÿããplatelet-derived factor concentrate (PFC)ãšPRPé¢ç¯å 泚å°çæ³ã®èšåºæ¯èŒç 究第18ååçå»çåŠäŒç·äŒ2019
- [3]â§Dai WL, et al. Efficacy of Platelet-Rich Plasma in the Treatment of Knee Osteoarthritis: A Meta-analysis of Randomized Controlled Trials. Arthroscopy. 2017 Mar;33(3):659-670.
- [4]â§J Araki, et al. Optimized preparation method of platelet-concentrated plasma and noncoagulating platelet-derived factor concentrates: maximization of platelet concentration and removal of fibrinogen. Tissue Eng Part C Methods. 2012 Mar;18(3):176-85.
- [5]â§æšªç°çŽæ£ã»ã å€åœ¢æ§èé¢ç¯çã«å¯Ÿããplatelet-derived factor concentrate (PFC)ãšPRPé¢ç¯å 泚å°çæ³ã®èšåºæ¯èŒç ç©¶ 第18ååçå»çåŠäŒç·äŒ




